Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)

NCT04452942 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-07-21

No results posted yet for this study

Summary

This study is a prospective, single center, observational, cohort study of patients to (1) describe the kinetics and temporal relationship of changes in eicosanoid and cytokine mediators in patients with severe COVID-19 admitted to the hospital; and (2) correlate the dynamic changes in eicosanoid mediators with available patient clinical status, including measures of severity of illness, routine laboratory tests, and outcomes.

Conditions

Sponsors & Collaborators

  • EicOsis Human Health Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-31
Primary Completion
2020-09-30
Completion
2021-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04452942 on ClinicalTrials.gov